Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS)
Go back to Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS)| (NASDAQ: SGHT) | Delayed: 5.41 +0.17 (3.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.24 | 52 Week High | $ | |||
| Open | $5.17 | 52 Week Low | $ | |||
| Day High | $5.47 | P/E | N/A | |||
| Day Low | $4.98 | EPS | $ | |||
| Volume | 109,426 | |||||
